“Nudging” in microbiological reports: a strategy to improve prescribing

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.


  1. 1.

    Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis. 2005;5:450–9.

  2. 2.

    Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, Ramsay CR, Wiffen PJ, Wilcox M. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.

  3. 3.

    Spellberg B. Antibiotic judo: working gently with prescriber psychology to overcome inappropriate use. JAMA Intern Med. 2014;174:432–3.

  4. 4.

    Charani E, Castro-Sanchez E, Sevdalis N, Kyratsis Y, Drumright L, Shah N, Holmes A. Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette”. Clin Infect Dis. 2013;57:188–96.

  5. 5.

    de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, Geiss HK, Janata O, Krause R, Lemmen S, Meyer E, Mittermayer H, Porsche U, Presterl E, Reuter S, Sinha B, Strauß R, Wechsler-Fördös A, Wenisch C, Kern WV. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection. 2016;44:395–439.

  6. 6.

    Borde JP, Kaier K, Steib-Bauert M, Vach W, Geibel-Zehender A, Busch H, Bertz H, Hug M, de With K, Kern WV. Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infect Dis. 2014;14:201.

  7. 7.

    Borde JP, Litterst S, Ruhnke M, Feik R, Hübner J, deWith K, Kaier K, Kern WV. Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany. Infection. 2015;43:45–50.

  8. 8.

    Katchanov J, Wöstmann K, Tominski D, Jefferys L, Liedtke A, Schneider A, Slevogt H, Arastéh K, Stocker H. Burden and spectrum of infectious disease in Germany 2009–2014: a multicentre study from Berlin’s Municipal Hospitals. Infection. 2016;44:187–95.

  9. 9.

    Pope SD, Dellit TH, Owens RC, Hooton TM. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol. 2009;30:97–8.

  10. 10.

    Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth, and happiness. New Haven: Yale University Press; 2008.

  11. 11.

    Hansen PG, Skov LR, Skov KL. Making healthy choices easier: regulation versus nudging. Annu Rev Public Health. 2016;37:237–51.

  12. 12.

    Boog MC, Erasmus V, de Graaf JM, van Beeck EA, Melles M, van Beeck EF. Assessing the optimal location for alcohol-based hand rub dispensers in a patient room in an intensive care unit. BMC Infect Dis. 2013;13:510.

  13. 13.

    Meeker D, Knight TK, Friedberg MW, Linder JA, Goldstein NJ, Fox CR, Rothfeld A, Diaz G, Doctor JN. Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial. JAMA Intern Med. 2014;174:425–31.

  14. 14.

    Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Knight TK, Hay JW, Doctor JN. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA. 2016;315:562–70.

  15. 15.

    Gerber JS. Improving outpatient antibiotic prescribing: another nudge in the right direction. JAMA. 2016;315:558–9.

  16. 16.

    Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis. 2009;48:S238–45.

  17. 17.

    Shafazand S, Weinacker AB. Blood cultures in the critical care unit: improving utilization and yield. Chest. 2002;122:1727–36.

  18. 18.

    Katsios CM, Burry L, Nelson S, Jivraj T, Lapinsky SE, Wax RS, Christian M, Mehta S, Bell CM, Morris AM. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care. 2012;16:R216.

  19. 19.

    Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL. Moreno R; Surviving Sepsis Campaign Guidelines Committee including the pediatric subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.

  20. 20.

    Lee CC, Lee NY, Chen PL, Hong MY, Chan TY, Chi CH, Ko WC. Impact of antimicrobial strategies on clinical outcomes of adults with septic shock and community-onset Enterobacteriaceae bacteremia: de-escalation is beneficial. Diagn Microbiol Infect Dis. 2015;82:158–64.

  21. 21.

    Rodvold KA, McConeghy KW. Methicillin-resistant Staphylococcus aureus therapy: past, present, and future. Clin Infect Dis. 2014;58:S20–7.

  22. 22.

    Rice LB. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. Clin Infect Dis. 2008;46:491–6.

  23. 23.

    Bartlett RC. A plea for clinical relevance in medical microbiology. Am J Clin Pathol. 1974;61:867–72.

  24. 24.

    Lee A, Gooden H. Improving communication of microbiology test results. Am J Clin Pathol. 1982;77:443–6.

  25. 25.

    Persell SD, Friedberg MW, Meeker D, Linder JA, Fox CR, Goldstein NJ, Shah PD, Knight TK, Doctor JN. Use of behavioral economics and social psychology to improve treatment of acute respiratory infections (BEARI): rationale and design of a cluster randomized controlled trial [1RC4AG039115-01]—study protocol and baseline practice and provider characteristics. BMC Infect Dis. 2013;13:290.

Download references

Author information

Correspondence to Achim J. Kaasch.

Ethics declarations

Conflict of interest

A.J.K. received grants from the Deutsche Forschungsgemeinschaft and Bundesministerium für Bildung und Forschung. A.J.K. received payments for lectures from BD Biosciences, bioMérieux, MSD Sharp & Dohme, Limbach Gruppe SE, and ViiV Healthcare; A.J.K. received travel support from Janssen-Cilag. S.K. received grants from the NovaLung und Pfizer. S.K. received payments for lectures from Astellas, Basilea, Biotest, Cytosorbents, Gambro, Gilead, MSD, NovaLung, Pfizer, Orion, Sedana, Sorin, Thermo Fisher Scientific, and for advisory activities from AMOMED, Astellas, Cubist, Gambro, Gilead, MSD, NovaLung, Novartis, and Pfizer. The other authors declare that they have no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Katchanov, J., Kluge, S., MacKenzie, C.R. et al. “Nudging” in microbiological reports: a strategy to improve prescribing. Infection 45, 123–127 (2017) doi:10.1007/s15010-016-0938-3

Download citation


  • Antimicrobial Therapy
  • Clostridium Difficile Infection
  • Daptomycin
  • Hospital Information System
  • Antimicrobial Prescribe